SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

[December 04, 2013]

Research and Markets: LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/mx8gz6/ly2605541_type_2) has announced the addition of the "LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022" report to their offering.

GlobalData has released its new report, LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than doubling over this period. The main drivers of growth will be the dramatic increase in disease prevalence and physicians' efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combinationtherapies and novel branded drugs.


Insulin peglispro (LY2605541) is a novel basal insulin analog being developed by Eli Lilly and Boehringer Ingelheim, currently in Phase III clinical trials.

Scope

- Overview of type 2 diabetes, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on LY2605541 including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for LY2605541 for the top ten countries from 2012 to 2022.

- Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, India and China.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return

- Stay ahead of the competition by understanding the changing competitive landscape for type 2 diabetes

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

- Make more informed business decisions from insightful and in-depth analysis of LY2605541 performance

- Obtain sales forecast for LY2605541 from 2012-2022 in top ten countries (the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, India and China)

For more information visit http://www.researchandmarkets.com/research/mx8gz6/ly2605541_type_2

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.